Table of Content

1 Report Overview

1.1 Study Scope and Definition

1.2 Research Methodology

1.2.1 Methodology/Research Approach

1.2.2 Data Source

1.3 Key Market Segments

1.4 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue

1.5 Market Analysis by Type

1.5.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2021 VS 2027

1.5.2 Monotherapy

1.5.3 Combination Therapy

1.6 Market by Application

1.6.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2022-2027

1.6.2 Hematologic Malignancies

1.6.3 Solid Malignancies

1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections

1.7.2 Covid-19 Impact: Commodity Prices Indices

1.7.3 Covid-19 Impact: Global Major Government Policy

1.8 Study Objectives

1.9 Years Considered

2 Global CAR T-Cell Immunotherapy Market Trends and Growth Strategy

2.1 Market Top Trends

2.2 Market Drivers

2.3 Market Challenges

2.4 Porter’s Five Forces Analysis

2.5 Market Growth Strategy

2.6 SWOT Analysis

3 Global CAR T-Cell Immunotherapy Market Players Profiles

3.1 AbbVie

3.1.1 AbbVie Company Profile

3.1.2 AbbVie CAR T-Cell Immunotherapy Product Specification

3.1.3 AbbVie CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.2 Celgene

3.2.1 Celgene Company Profile

3.2.2 Celgene CAR T-Cell Immunotherapy Product Specification

3.2.3 Celgene CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.3 Kite Pharma

3.3.1 Kite Pharma Company Profile

3.3.2 Kite Pharma CAR T-Cell Immunotherapy Product Specification

3.3.3 Kite Pharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.4 Oxford BioMedica

3.4.1 Oxford BioMedica Company Profile

3.4.2 Oxford BioMedica CAR T-Cell Immunotherapy Product Specification

3.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.5 Novartis

3.5.1 Novartis Company Profile

3.5.2 Novartis CAR T-Cell Immunotherapy Product Specification

3.5.3 Novartis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.6 Gilead

3.6.1 Gilead Company Profile

3.6.2 Gilead CAR T-Cell Immunotherapy Product Specification

3.6.3 Gilead CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.7 Pfizer

3.7.1 Pfizer Company Profile

3.7.2 Pfizer CAR T-Cell Immunotherapy Product Specification

3.7.3 Pfizer CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.8 Cellectis

3.8.1 Cellectis Company Profile

3.8.2 Cellectis CAR T-Cell Immunotherapy Product Specification

3.8.3 Cellectis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.9 Bellicum

3.9.1 Bellicum Company Profile

3.9.2 Bellicum CAR T-Cell Immunotherapy Product Specification

3.9.3 Bellicum CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.10 Mustang Bio

3.10.1 Mustang Bio Company Profile

3.10.2 Mustang Bio CAR T-Cell Immunotherapy Product Specification

3.10.3 Mustang Bio CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.11 CARsgen Therapeutics

3.11.1 CARsgen Therapeutics Company Profile

3.11.2 CARsgen Therapeutics CAR T-Cell Immunotherapy Product Specification

3.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.12 Xyphos

3.12.1 Xyphos Company Profile

3.12.2 Xyphos CAR T-Cell Immunotherapy Product Specification

3.12.3 Xyphos CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.13 Minerva Biotechnologies

3.13.1 Minerva Biotechnologies Company Profile

3.13.2 Minerva Biotechnologies CAR T-Cell Immunotherapy Product Specification

3.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.14 Adaptimmune

3.14.1 Adaptimmune Company Profile

3.14.2 Adaptimmune CAR T-Cell Immunotherapy Product Specification

3.14.3 Adaptimmune CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.15 Ziopharm Oncology

3.15.1 Ziopharm Oncology Company Profile

3.15.2 Ziopharm Oncology CAR T-Cell Immunotherapy Product Specification

3.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.16 Aurora Biopharma

3.16.1 Aurora Biopharma Company Profile

3.16.2 Aurora Biopharma CAR T-Cell Immunotherapy Product Specification

3.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

3.17 Creative Biolabs

3.17.1 Creative Biolabs Company Profile

3.17.2 Creative Biolabs CAR T-Cell Immunotherapy Product Specification

3.17.3 Creative Biolabs CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

4 Global CAR T-Cell Immunotherapy Market Competition by Market Players

4.1 Global CAR T-Cell Immunotherapy Production Capacity Market Share by Market Players (2016-2021)

4.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Market Players (2016-2021)

4.3 Global CAR T-Cell Immunotherapy Average Price by Market Players (2016-2021)

5 Global CAR T-Cell Immunotherapy Production by Regions (2016-2021)

5.1 North America

5.1.1 North America CAR T-Cell Immunotherapy Market Size (2016-2021)

5.1.2 CAR T-Cell Immunotherapy Key Players in North America (2016-2021)

5.1.3 North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.1.4 North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.2 East Asia

5.2.1 East Asia CAR T-Cell Immunotherapy Market Size (2016-2021)

5.2.2 CAR T-Cell Immunotherapy Key Players in East Asia (2016-2021)

5.2.3 East Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.2.4 East Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.3 Europe

5.3.1 Europe CAR T-Cell Immunotherapy Market Size (2016-2021)

5.3.2 CAR T-Cell Immunotherapy Key Players in Europe (2016-2021)

5.3.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.3.4 Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.4 South Asia

5.4.1 South Asia CAR T-Cell Immunotherapy Market Size (2016-2021)

5.4.2 CAR T-Cell Immunotherapy Key Players in South Asia (2016-2021)

5.4.3 South Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.4.4 South Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.5 Southeast Asia

5.5.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2016-2021)

5.5.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia (2016-2021)

5.5.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.5.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.6 Middle East

5.6.1 Middle East CAR T-Cell Immunotherapy Market Size (2016-2021)

5.6.2 CAR T-Cell Immunotherapy Key Players in Middle East (2016-2021)

5.6.3 Middle East CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.6.4 Middle East CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.7 Africa

5.7.1 Africa CAR T-Cell Immunotherapy Market Size (2016-2021)

5.7.2 CAR T-Cell Immunotherapy Key Players in Africa (2016-2021)

5.7.3 Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.7.4 Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.8 Oceania

5.8.1 Oceania CAR T-Cell Immunotherapy Market Size (2016-2021)

5.8.2 CAR T-Cell Immunotherapy Key Players in Oceania (2016-2021)

5.8.3 Oceania CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.8.4 Oceania CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.9 South America

5.9.1 South America CAR T-Cell Immunotherapy Market Size (2016-2021)

5.9.2 CAR T-Cell Immunotherapy Key Players in South America (2016-2021)

5.9.3 South America CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.9.4 South America CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

5.10 Rest of the World

5.10.1 Rest of the World CAR T-Cell Immunotherapy Market Size (2016-2021)

5.10.2 CAR T-Cell Immunotherapy Key Players in Rest of the World (2016-2021)

5.10.3 Rest of the World CAR T-Cell Immunotherapy Market Size by Type (2016-2021)

5.10.4 Rest of the World CAR T-Cell Immunotherapy Market Size by Application (2016-2021)

6 Global CAR T-Cell Immunotherapy Consumption by Region (2016-2021)

6.1 North America

6.1.1 North America CAR T-Cell Immunotherapy Consumption by Countries

6.1.2 United States

6.1.3 Canada

6.1.4 Mexico

6.2 East Asia

6.2.1 East Asia CAR T-Cell Immunotherapy Consumption by Countries

6.2.2 China

6.2.3 Japan

6.2.4 South Korea

6.3 Europe

6.3.1 Europe CAR T-Cell Immunotherapy Consumption by Countries

6.3.2 Germany

6.3.3 United Kingdom

6.3.4 France

6.3.5 Italy

6.3.6 Russia

6.3.7 Spain

6.3.8 Netherlands

6.3.9 Switzerland

6.3.10 Poland

6.4 South Asia

6.4.1 South Asia CAR T-Cell Immunotherapy Consumption by Countries

6.4.2 India

6.5 Southeast Asia

6.5.1 Southeast Asia CAR T-Cell Immunotherapy Consumption by Countries

6.5.2 Indonesia

6.5.3 Thailand

6.5.4 Singapore

6.5.5 Malaysia

6.5.6 Philippines

6.6 Middle East

6.6.1 Middle East CAR T-Cell Immunotherapy Consumption by Countries

6.6.2 Turkey

6.6.3 Saudi Arabia

6.6.4 Iran

6.6.5 United Arab Emirates

6.7 Africa

6.7.1 Africa CAR T-Cell Immunotherapy Consumption by Countries

6.7.2 Nigeria

6.7.3 South Africa

6.8 Oceania

6.8.1 Oceania CAR T-Cell Immunotherapy Consumption by Countries

6.8.2 Australia

6.9 South America

6.9.1 South America CAR T-Cell Immunotherapy Consumption by Countries

6.9.2 Brazil

6.9.3 Argentina

6.10 Rest of the World

6.10.1 Rest of the World CAR T-Cell Immunotherapy Consumption by Countries

7 Global CAR T-Cell Immunotherapy Production Forecast by Regions (2022-2027)

7.1 Global Forecasted Production of CAR T-Cell Immunotherapy (2022-2027)

7.2 Global Forecasted Revenue of CAR T-Cell Immunotherapy (2022-2027)

7.3 Global Forecasted Price of CAR T-Cell Immunotherapy (2022-2027)

7.4 Global Forecasted Production of CAR T-Cell Immunotherapy by Region (2022-2027)

7.4.1 North America CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.2 East Asia CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.3 Europe CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.4 South Asia CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.5 Southeast Asia CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.6 Middle East CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.7 Africa CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.8 Oceania CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.9 South America CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.4.10 Rest of the World CAR T-Cell Immunotherapy Production, Revenue Forecast (2022-2027)

7.5 Forecast by Type and by Application (2022-2027)

7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027)

7.5.2 Global Forecasted Consumption of CAR T-Cell Immunotherapy by Application (2022-2027)

8 Global CAR T-Cell Immunotherapy Consumption Forecast by Regions (2022-2027)

8.1 North America Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.2 East Asia Market Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.3 Europe Market Forecasted Consumption of CAR T-Cell Immunotherapy by Countriy

8.4 South Asia Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.5 Southeast Asia Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.6 Middle East Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.7 Africa Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.8 Oceania Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.9 South America Forecasted Consumption of CAR T-Cell Immunotherapy by Country

8.10 Rest of the world Forecasted Consumption of CAR T-Cell Immunotherapy by Country

9 Global CAR T-Cell Immunotherapy Sales by Type (2016-2027)

9.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2016-2021)

9.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027)

10 Global CAR T-Cell Immunotherapy Consumption by Application (2016-2027)

10.1 Global CAR T-Cell Immunotherapy Historic Market Size by Application (2016-2021)

10.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027)

11 Global CAR T-Cell Immunotherapy Manufacturing Cost Analysis

11.1 CAR T-Cell Immunotherapy Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.3 Manufacturing Process Analysis of CAR T-Cell Immunotherapy

12 Global CAR T-Cell Immunotherapy Marketing Channel, Distributors, Customers and Supply Chain

12.1 Marketing Channel

12.2 CAR T-Cell Immunotherapy Distributors List

12.3 CAR T-Cell Immunotherapy Customers

12.4 CAR T-Cell Immunotherapy Supply Chain Analysis

13 Analyst's Viewpoints/Conclusions

14 Disclaimer

List of Figure

Table 1. Research Programs/Design for This Report

Table 2. Key Data Information from Secondary Sources

Table 3. Key Executives Interviewed

Table 4. Key Data Information from Primary Sources

Table 5. Key Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue (US$ Million) 2016-2021

Table 6. Global CAR T-Cell Immunotherapy Market Size by Type (US$ Million): 2022-2027

Table 7. Monotherapy Features

Table 8. Combination Therapy Features

Table 16. Global CAR T-Cell Immunotherapy Market Size by Application (US$ Million): 2022-2027

Table 17. Hematologic Malignancies Case Studies

Table 18. Solid Malignancies Case Studies

Table 26. Overview of the World Economic Outlook Projections

Table 27. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

Table 28. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 29. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 30. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 31. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

Table 32. Commodity Prices-Metals Price Indices

Table 33. Commodity Prices- Precious Metal Price Indices

Table 34. Commodity Prices- Agricultural Raw Material Price Indices

Table 35. Commodity Prices- Food and Beverage Price Indices

Table 36. Commodity Prices- Fertilizer Price Indices

Table 37. Commodity Prices- Energy Price Indices

Table 38. G20+: Economic Policy Responses to COVID-19

Table 39. Covid-19 Impact: Global Major Government Policy

Table 40. CAR T-Cell Immunotherapy Report Years Considered

Table 41. Market Top Trends

Table 42. Key Drivers: Impact Analysis

Table 43. Key Challenges

Table 44. Porter's Five Forces Analysis

Table 45. CAR T-Cell Immunotherapy Market Growth Strategy

Table 46. CAR T-Cell Immunotherapy SWOT Analysis

Table 47. AbbVie CAR T-Cell Immunotherapy Product Specification

Table 48. AbbVie CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 49. Celgene CAR T-Cell Immunotherapy Product Specification

Table 50. Celgene CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 51. Kite Pharma CAR T-Cell Immunotherapy Product Specification

Table 52. Kite Pharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 53. Oxford BioMedica CAR T-Cell Immunotherapy Product Specification

Table 54. Table Oxford BioMedica CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 55. Novartis CAR T-Cell Immunotherapy Product Specification

Table 56. Novartis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 57. Gilead CAR T-Cell Immunotherapy Product Specification

Table 58. Gilead CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 59. Pfizer CAR T-Cell Immunotherapy Product Specification

Table 60. Pfizer CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 61. Cellectis CAR T-Cell Immunotherapy Product Specification

Table 62. Cellectis CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 63. Bellicum CAR T-Cell Immunotherapy Product Specification

Table 64. Bellicum CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 65. Mustang Bio CAR T-Cell Immunotherapy Product Specification

Table 66. Mustang Bio CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 67. CARsgen Therapeutics CAR T-Cell Immunotherapy Product Specification

Table 68. CARsgen Therapeutics CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 69. Xyphos CAR T-Cell Immunotherapy Product Specification

Table 70. Xyphos CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 71. Minerva Biotechnologies CAR T-Cell Immunotherapy Product Specification

Table 72. Minerva Biotechnologies CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 73. Adaptimmune CAR T-Cell Immunotherapy Product Specification

Table 74. Adaptimmune CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 75. Ziopharm Oncology CAR T-Cell Immunotherapy Product Specification

Table 76. Ziopharm Oncology CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 77. Aurora Biopharma CAR T-Cell Immunotherapy Product Specification

Table 78. Aurora Biopharma CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 79. Creative Biolabs CAR T-Cell Immunotherapy Product Specification

Table 80. Creative Biolabs CAR T-Cell Immunotherapy Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Table 147. Global CAR T-Cell Immunotherapy Production Capacity by Market Players

Table 148. Global CAR T-Cell Immunotherapy Production by Market Players (2016-2021)

Table 149. Global CAR T-Cell Immunotherapy Production Market Share by Market Players (2016-2021)

Table 150. Global CAR T-Cell Immunotherapy Revenue by Market Players (2016-2021)

Table 151. Global CAR T-Cell Immunotherapy Revenue Share by Market Players (2016-2021)

Table 152. Global Market CAR T-Cell Immunotherapy Average Price of Key Market Players (2016-2021)

Table 153. North America Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 154. North America Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 155. North America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 156. North America CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 157. North America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 158. North America CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 159. East Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 160. East Asia Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 161. East Asia Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 162. East Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 163. East Asia CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 164. East Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 165. East Asia CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 166. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 167. Europe Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 168. Europe Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 169. Europe CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 170. Europe CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 171. Europe CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 172. Europe CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 173. South Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 174. South Asia Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 175. South Asia Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 176. South Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 177. South Asia CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 178. South Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 179. South Asia CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 180. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 181. Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 182. Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 183. Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 184. Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 185. Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 186. Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 187. Middle East CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 188. Middle East Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 189. Middle East Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 190. Middle East CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 191. Middle East CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 192. Middle East CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 193. Middle East CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 194. Africa CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 195. Africa Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 196. Africa Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 197. Africa CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 198. Africa CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 199. Africa CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 200. Africa CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 201. Oceania CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 202. Oceania Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 203. Oceania Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 204. Oceania CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 205. Oceania CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 206. Oceania CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 207. Oceania CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 208. South America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 209. South America Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 210. South America Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 211. South America CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 212. South America CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 213. South America CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 214. South America CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 215. Rest of the World CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Table 216. Rest of the World Key Players CAR T-Cell Immunotherapy Revenue (2016-2021) (US$ Million)

Table 217. Rest of the World Key Players CAR T-Cell Immunotherapy Market Share (2016-2021)

Table 218. Rest of the World CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 219. Rest of the World CAR T-Cell Immunotherapy Market Share by Type (2016-2021)

Table 220. Rest of the World CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 221. Rest of the World CAR T-Cell Immunotherapy Market Share by Application (2016-2021)

Table 222. North America CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 223. East Asia CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 224. Europe CAR T-Cell Immunotherapy Consumption by Region (2016-2021)

Table 225. South Asia CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 226. Southeast Asia CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 227. Middle East CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 228. Africa CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 229. Oceania CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 230. South America CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 231. Rest of the World CAR T-Cell Immunotherapy Consumption by Countries (2016-2021)

Table 232. Global CAR T-Cell Immunotherapy Production Forecast by Region (2022-2027)

Table 233. Global CAR T-Cell Immunotherapy Sales Volume Forecast by Type (2022-2027)

Table 234. Global CAR T-Cell Immunotherapy Sales Volume Market Share Forecast by Type (2022-2027)

Table 235. Global CAR T-Cell Immunotherapy Sales Revenue Forecast by Type (2022-2027)

Table 236. Global CAR T-Cell Immunotherapy Sales Revenue Market Share Forecast by Type (2022-2027)

Table 237. Global CAR T-Cell Immunotherapy Sales Price Forecast by Type (2022-2027)

Table 238. Global CAR T-Cell Immunotherapy Consumption Volume Forecast by Application (2022-2027)

Table 239. Global CAR T-Cell Immunotherapy Consumption Value Forecast by Application (2022-2027)

Table 240. North America CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 241. East Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 242. Europe CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 243. South Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 244. Southeast Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 245. Middle East CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 246. Africa CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 247. Oceania CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 248. South America CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 249. Rest of the world CAR T-Cell Immunotherapy Consumption Forecast 2022-2027 by Country

Table 250. Global CAR T-Cell Immunotherapy Market Size by Type (2016-2021) (US$ Million)

Table 251. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2016-2021)

Table 252. Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)

Table 253. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2022-2027)

Table 254. Global CAR T-Cell Immunotherapy Market Size by Application (2016-2021) (US$ Million)

Table 255. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2016-2021)

Table 256. Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)

Table 257. Global CAR T-Cell Immunotherapy Revenue Market Share by Application (2022-2027)

Table 258. CAR T-Cell Immunotherapy Distributors List

Table 259. CAR T-Cell Immunotherapy Customers List





Figure 1. Product Figure

Figure 2. Global CAR T-Cell Immunotherapy Market Share by Type: 2021 VS 2027

Figure 3. Global CAR T-Cell Immunotherapy Market Share by Application: 2021 VS 2027

Figure 4. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2016-2021) (US$ Million)

Figure 5. North America CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 6. North America CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 7. United States CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 8. Canada CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 9. Mexico CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 10. East Asia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 11. East Asia CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 12. China CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 13. Japan CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 14. South Korea CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 15. Europe CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 16. Europe CAR T-Cell Immunotherapy Consumption Market Share by Region in 2021

Figure 17. Germany CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 18. United Kingdom CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 19. France CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 20. Italy CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 21. Russia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 22. Spain CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 23. Netherlands CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 24. Switzerland CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 25. Poland CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 26. South Asia CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 27. South Asia CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 28. India CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 29. Southeast Asia CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 30. Southeast Asia CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 31. Indonesia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 32. Thailand CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 33. Singapore CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 34. Malaysia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 35. Philippines CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 36. Middle East CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 37. Middle East CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 38. Turkey CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 39. Saudi Arabia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 40. Iran CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 41. United Arab Emirates CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 42. Africa CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 43. Africa CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 44. Nigeria CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 45. South Africa CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 46. Oceania CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 47. Oceania CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 48. Australia CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 49. South America CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 50. South America CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 51. Brazil CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 52. Argentina CAR T-Cell Immunotherapy Consumption and Growth Rate (2016-2021)

Figure 53. Rest of the World CAR T-Cell Immunotherapy Consumption and Growth Rate

Figure 54. Rest of the World CAR T-Cell Immunotherapy Consumption Market Share by Countries in 2021

Figure 55. Global CAR T-Cell Immunotherapy Production Capacity Growth Rate Forecast (2022-2027)

Figure 56. Global CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 57. Global CAR T-Cell Immunotherapy Price and Trend Forecast (2022-2027)

Figure 58. North America CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 59. North America CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 60. East Asia CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 61. East Asia CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 62. Europe CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 63. Europe CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 64. South Asia CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 65. South Asia CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 66. Southeast Asia CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 67. Southeast Asia CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 68. Middle East CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 69. Middle East CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 70. Africa CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 71. Africa CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 72. Oceania CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 73. Oceania CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 74. South America CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 75. South America CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 76. Rest of the World CAR T-Cell Immunotherapy Production Growth Rate Forecast (2022-2027)

Figure 77. Rest of the World CAR T-Cell Immunotherapy Revenue Growth Rate Forecast (2022-2027)

Figure 78. North America CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 79. East Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 80. Europe CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 81. South Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 82. Southeast Asia CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 83. Middle East CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 84. Africa CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 85. Oceania CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 86. South America CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 87. Rest of the world CAR T-Cell Immunotherapy Consumption Forecast 2022-2027

Figure 88. Manufacturing Cost Structure of CAR T-Cell Immunotherapy

Figure 89. Manufacturing Process Analysis of CAR T-Cell Immunotherapy

Figure 90. Channels of Distribution

Figure 91. Distributors Profiles

Figure 92. CAR T-Cell Immunotherapy Supply Chain Analysis